68252 Federal Register / Vol. 79, No. 220 / Friday, November 14, 2014 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention) 

Subcommittee for Dose 

Reconstruction Reviews (SDRR), 

Advisory Board on Radiation and 

Worker Health (ABRWH or the 

Advisory Board), National Institute for 

Occupational Safety and Health 

(NIOSH) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC), 

announces the following meeting for the 

aforementioned subcommittee: 

Time and Date: 10:30 a.m.–5:00 p.m. 

Eastern Time, December 8, 2014. 

Place: Audio Conference Call via FTS 

Conferencing. 

Status: Open to the public, but 

without a public comment period. The 

public is welcome to submit written 

comments in advance of the meeting, to 

the contact person below. Written 

comments received in advance of the 

meeting will be included in the official 

record of the meeting. The public is also 

welcome to listen to the meeting by 

joining the teleconference at the USA 

toll-free, dial-in number 1–866–659– 

0537 and the pass code is 9933701. 

Background: The Advisory Board was 

established under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000 to advise the 

President on a variety of policy and 

technical functions required to 

implement and effectively manage the 

new compensation program. Key 

functions of the Advisory Board include 

providing advice on the development of 

probability of causation guidelines that 

have been promulgated by the 

Department of Health and Human 

Services (HHS) as a final rule; advice on 

methods of dose reconstruction, which 

have also been promulgated by HHS as 

a final rule; advice on the scientific 

validity and quality of dose estimation 

and reconstruction efforts being 

performed for purposes of the 

compensation program; and advice on 

petitions to add classes of workers to the 

Special Exposure Cohort. 

In December 2000, the President 

delegated responsibility for funding, 

staffing, and operating the Advisory 

Board to HHS, which subsequently 

delegated this authority to CDC. NIOSH 

implements this responsibility for CDC. 

The charter was issued on August 3, 

2001, renewed at appropriate intervals, 

and will expire on August 3, 2015. 

Purpose: The Advisory Board is 

charged with (a) providing advice to the 

Secretary, HHS, on the development of 

guidelines under Executive Order 

13179; (b) providing advice to the 

Secretary, HHS, on the scientific 

validity and quality of dose 

reconstruction efforts performed for this 

program; and (c) upon request by the 

Secretary, HHS, advise the Secretary on 

whether there is a class of employees at 

any Department of Energy facility who 

were exposed to radiation but for whom 

it is not feasible to estimate their 

radiation dose, and on whether there is 

reasonable likelihood that such 

radiation doses may have endangered 

the health of members of this class. The 

Subcommittee for Dose Reconstruction 

Reviews was established to aid the 

Advisory Board in carrying out its duty 

to advise the Secretary, HHS, on dose 

reconstruction. 

Matters To Be Discussed: The agenda 

for the Subcommittee meeting includes 

the following dose reconstruction 

program quality management and 

assurance activities: Discussion of 

current findings from NIOSH and 

Advisory Board dose reconstruction 

blind reviews; discussion of dose 

reconstruction cases under review 

(cases involving Y–12, Oak Ridge 

National Laboratory, Lawrence 

Livermore National Laboratory, 

Simonds Saw and Steel, Weldon Spring, 

W.R. Grace, Westinghouse, International 

Minerals and Chemical (IMC) 

Corporation, Koppers Company, 

Bridgeport Brass, Uranium Mill in 

Monticello,); and preparation of the 

Advisory Board’s next report to the 

Secretary, HHS, summarizing the results 

of completed dose reconstruction 

reviews. 

The agenda is subject to change as 

priorities dictate. 

Contact Person for More Information: 

Theodore Katz, Designated Federal 

Officer, NIOSH, CDC, 1600 Clifton 

Road, Mailstop E–20, Atlanta, Georgia 

30333, Telephone (513) 533–6800, Toll 

Free 1(800)CDC–INFO, Email ocas@

cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Claudette Grant, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 2014–26913 Filed 11–13–14; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Board of Scientific Counselors, Office 

of Infectious Diseases (BSC, OID) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC), 

announces the following meeting of the 

aforementioned committee: 

Time and Date: 8:00 a.m.–5:00 p.m., 

December 10, 2014. 

Place: CDC, Global Communications 

Center, 1600 Clifton Road NE., Building 19, 

Auditorium B3, Atlanta, Georgia 30333. 

Status: The meeting is open to the public, 

limited only by the space available. 

Purpose: The BSC, OID, provides advice 

and guidance to the Secretary, Department of 

Health and Human Services; the Director, 

CDC; the Director, OID; and the Directors of 

the National Center for Immunization and 

Respiratory Diseases, the National Center for 

Emerging and Zoonotic Infectious Diseases, 

and the National Center for HIV/AIDS, Viral 

Hepatitis, STD, and TB Prevention, CDC, in 

the following areas: Strategies, goals, and 

priorities for programs; research within the 

national centers; and overall strategic 

direction and focus of OID and the national 

centers. 

Matters To Be Discussed: The meeting will 

include reports from the BSC, OID working 

groups; brief updates on priorities/activities 

of CDC’s infectious disease national centers; 

and a focused discussion on public health 

issues arising from long-term outbreak 

response efforts. 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: 

Robin Moseley, M.A.T., Designated Federal 

Officer, OID, CDC, 1600 Clifton Road NE., 

Mailstop D10, Atlanta, Georgia 30333, 

Telephone: (404) 639–4461. 

The Director, Management Analysis and 

Services Office has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Claudette Grant, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 2014–26912 Filed 11–13–14; 8:45 am] 

BILLING CODE 4163–18–P 

mstockstill on DSK4VPTVN1PROD with NOTICES